AdvertiseDonate
Los AngelesNew YorkChicagoHoustonPhoenixPhiladelphiaSan FranciscoSeattleAtlantaBoston
Sunday, November 15, 2026News you can follow.
Global Newz Hub · 111 North Market Street, Suite 300, San Jose, CA 95113

Latest stories

  1. Top South Korean Tax Accountant Scorer Admits to Using AI in Exam
  2. Two educators arrested after hammer and screwdriver attack on kindergarten assistant
  3. Al Jazeera English marks two decades of global broadcasting
  4. Hundreds attend wedding of former Gaza hostage Bilal Ziyadne in Rahat
  5. With election over, US turns up pressure on Israel over winter aid for Gaza
World · Puget Sound

1,200% Rise in Kratom Poison Control Calls Precedes New Federal 7-OH Restrictions

New rules targeting concentrated kratom derivatives may take effect by November 13, 2026, as user data shows a sharp spike in health-related calls over the past decade.

By Marina Weber ·

Illustration for: 1,200% Rise in Kratom Poison Control Calls Precedes New Federal 7-OH Restrictions
Illustration generated for this article, not a news photograph.

Kratom, a leaf from a tree in the coffee family, has become a popular tool for some individuals managing pain or opioid withdrawal, but a concentrated derivative known as 7-OH is drawing new federal attention.

A new restriction on specific 7-OH products could go into place as early as Friday, November 13, 2026. The move follows a decade of debate over whether these substances should remain legally available in the United States.

7-OH, or 7-hydroxymitragynine, is a psychoactive ingredient found in small amounts naturally in kratom. Researchers note that it acts more like an opioid in the brain than standard kratom leaf products. In recent years, highly concentrated forms of 7-OH have appeared in tablets, gummies, and chocolate bars at gas stations, smoke shops, and liquor stores.

Data from 53 U.S. poison control centers reveals a dramatic increase in user reports. Calls related to kratom rose by approximately 1,200 percent between 2015 and 2025. The report, authored by Chris Holstege, a professor of emergency medicine at the University of Virginia, also recorded 233 deaths associated with kratom during that same period.

Seventy-nine percent of those deaths involved multiple substances. Holstege noted that the most severe outcomes were linked to users combining kratom products with opioids, stimulants, or benzodiazepines. However, 62 percent of the poison control reports involved individuals using kratom without other drugs.

The federal regulatory path has been contentious. In August, the Drug Enforcement Administration listed three semi-synthetic opioids derived from 7-OH, including MGM-15, MGM-16, and mitragynine pseudoindoxyl, under the Controlled Substances Act. This action placed them alongside heroin and LSD.

Advocacy groups, such as the American Kratom Association, filed a federal lawsuit on August 26 to protect natural kratom products containing trace amounts of these compounds. In response, the Department of Health and Human Services issued a new recommendation on October 9. The DEA subsequently adjusted its plan to restrict only products with higher concentrations of 7-OH and related compounds, leaving traditional botanical kratom largely unaffected.

Users describe mixed experiences with the substances. Tyler, a 38-year-old who used kratom powders to quit opioids in his early 20s, turned to 7-OH tablets in early 2025. He reported that the tablets felt like a miracle, providing an opioid-like euphoria that eased stomach issues associated with leaf powders. However, he began taking 300 to 400 milligrams daily, roughly ten times the dose of other users.

Tyler eventually entered a rapid detox program in Michigan in March 2026 after struggling to stop. He described the withdrawal symptoms as debilitating, comparing the sensation to having the flu three times over. He said he did not believe he could have stopped without professional sedation.

Brian, a 41-year-old former user, reported even higher consumption. At the peak of his use, he took 1,200 milligrams of 7-OH daily, spending about $150 each day. He found the product at a gas station in 2022, where it was sold next to energy drinks. He described the initial effect as feeling exactly like opioids.

Brian quit cold turkey in April 2026. He stated that the withdrawal from 7-OH was more debilitating than his previous opioid withdrawal, causing fear, anxiety, and gastrointestinal issues. He lost the desire to leave his home during the process.

Angela Wilson, a 44-year-old from Delaware, offers a contrasting view. She has taken 32 to 40 milligrams of 7-OH daily for a year and a half to manage chronic pain from endometriosis. Without health insurance, she said losing access to the product would be devastating for her family. She described the medication as life-changing, allowing her to manage pain without the anxiety and shakiness she experienced with kratom powders.

More World · Report a business · Got a Story?

Get Global Newz Hub in your inboxNews you can follow. Free, a few times a week, unsubscribe any time.

Related stories

Get Global Newz Hub in your inboxNews you can follow. Free, a few times a week, unsubscribe any time.